無料プレビュー

Sinovac Biotech Ltd. (SVA) · NASDAQ Global Select

プロフィール

Sinovac Biotech Ltd is a China-based biopharmaceutical company that researches, develops, manufactures, and commercializes inactivated and live-attenuated vaccines for infectious diseases including hepatitis A & B, influenza, COVID-19, EV71 enterovirus, varicella, poliomyelitis, pneumococcal disease, mumps, rabies, and tetanus. Products are sold through a portfolio of over 15 branded vaccines marketed domestically in China and internationally across nearly 80 countries via subsidiaries and strategic partnerships. The company operates five manufacturing bases in China (Beijing, Dalian, Chengdu,

主要指標

株価: $6.47 (0.00%)
時価総額: 5億ドル
PER（今期予想）: —
PBR: 0.1
配当利回り: —
52週レンジ: $6.47 – $6.47
業種: Healthcare / Medical - Pharmaceuticals
上場: NASDAQ Global Select
構成銘柄: —

比較会社: RPRX Royalty Pharma plc、CORT Corcept Therapeutics Incorporated、WBA Walgreens Boots Alliance, Inc.、KNSA Kiniksa Pharmaceuticals International, plc、DNLI Denali Therapeutics Inc.、LQDA Liquidia Corporation、PBH Prestige Consumer Healthcare Inc.、CLDX Celldex Therapeutics, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2027-05-03 · 更新: 2026-10-09